Atlas FDA

DIASORIN ETI-AB-HAVK PLUS ASSAY

FDA premarket approval P890019/S009 · decided 2004-02-20

Approval details

PMA number
P890019
Supplement
S009
Supplement type
Special (Immediate Track)
Trade name
DIASORIN ETI-AB-HAVK PLUS ASSAY
Generic name
Hepatitis a test (antibody and igm antibody)
Applicant
Diasorin
Date received
2004-01-30
Decision date
2004-02-20
Days to decision
21 days
Decision code
APPR
Product code
LOL
Advisory committee
Microbiology
Expedited review
No
Location
Stillwater, MN
Statement
APPROVAL FOR THE FOLLOWING CHANGES TO THE PACKAGE INSERT: THE SUPPLEMENT CONTAINS A REVISION IN THE ASSAY PACKAGE INSERT THAT STATES "ALL LOTS OF INCUBATION BUFFER ARE INTERCHANGEABLE BETWEEN ETI-EBK PLUS, ETI-AB-EBK PLUS, ETI-AB-HAVK PLUS."

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
LIAISON ALDOSTERONE, LIAISON ALDOSTERONE CONTROL SET, LIAISON ALDOSTERONE CALIBRATION VERIFIERS (K130321)Diasorin2013-04-09